Details
| Stereochemistry | RACEMIC |
| Molecular Formula | 2C7H17N.H2O4S |
| Molecular Weight | 328.512 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.CCCCCC(C)N.CCCCCC(C)N
InChI
InChIKey=XKUUMWKWUZRRPD-UHFFFAOYSA-N
InChI=1S/2C7H17N.H2O4S/c2*1-3-4-5-6-7(2)8;1-5(2,3)4/h2*7H,3-6,8H2,1-2H3;(H2,1,2,3,4)
Tuaminoheptane (or 2-aminoheptane), a nasal decongestant that is on the list of prohibited substances published by the World Anti-Doping Agency due to its stimulating properties. Tuaminoheptane is a stimulant of the sympathetic nervous system, similarly to several other known drugs targeting norepinephrine transporter
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095203 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18500382 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17881789
Unknown
Route of Administration:
Nasal
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 310.201
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6411-75-2
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
WZK5LN5CNW
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
m11252
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL123693
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
27117
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
229-113-5
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
SUB05005MIG
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
100000086039
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
C065369
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
DTXSID9045845
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY | |||
|
22921
Created by
admin on Mon Mar 31 19:14:48 GMT 2025 , Edited by admin on Mon Mar 31 19:14:48 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD